栄養障害型表皮水疱症治療剤 - School corporation Juntendo

Title:

栄養障害型表皮水疱症治療剤

Document Type and Number:

Japanese Patent JP7141079

Kind Code:

B2

Abstract:

To provide a therapeutic agent for dystrophic epidermolysis bullosa designated as an incurable disease.SOLUTION: A dystrophic epidermolysis bullosa therapeutic agent has an epidermal keratinocyte progenitor expressing type VII collagen, differentiated and induced from fat tissue-derived stem cells, as an active ingredient.SELECTED DRAWING: None

More Like This:

WO/2011/150482	METHODS FOR OBTAINING REABSORBABLE COMPOSITES, COMPOSITES, MEMBRANE, SCAFFOLD AND ITS USES
WO/2002/061033	TRANSFECTION OF HUMAN EMBRYONIC STEM CELLS
WO/2000/056405	HUMAN TUMOR NECROSIS FACTOR RECEPTOR-LIKE 2

Inventors:

Shigeru Ikeda
Toshio Hasegawa

Application Number:

JP2018029385A

Publication Date:

September 22, 2022

Filing Date:

February 22, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

School corporation Juntendo

International Classes:

A61K35/36; A61P17/00

Domestic Patent References:

JP2016013070A

Other References:

Plos One, 2013, Vol.8 No.10, Article.e77673(p.1-9)
Sci Transl Med., 2014, Vol.6 No.264, Article.264ra163(p.1-23)

Attorney, Agent or Firm:

Alga Patent Office, a patent business corporation

Previous Patent: Printer and program

Next Patent: MULTI-VALUED OR CONTINUOUS-VALUED INPUT DEVICE